These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

907 related articles for article (PubMed ID: 33190321)

  • 1. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and hepatitis B infection.
    Alqahtani SA; Buti M
    Antivir Ther; 2020; 25(8):389-397. PubMed ID: 33616549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.
    Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM
    Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.
    Marcus N; Frizinsky S; Hagin D; Ovadia A; Hanna S; Farkash M; Maoz-Segal R; Agmon-Levin N; Broides A; Nahum A; Rosenberg E; Kuperman AA; Dinur-Schejter Y; Berkun Y; Toker O; Goldberg S; Confino-Cohen R; Scheuerman O; Badarneh B; Epstein-Rigbi N; Etzioni A; Dalal I; Somech R
    Front Immunol; 2020; 11():614086. PubMed ID: 33519822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver and Biliary Tract Disease in Patients with Coronavirus disease-2019 Infection.
    Ekpanyapong S; Reddy KR
    Gastroenterol Clin North Am; 2023 Mar; 52(1):13-36. PubMed ID: 36813421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and comorbidities of hepatic diseases in a global perspective.
    Ahmad A; Ishtiaq SM; Khan JA; Aslam R; Ali S; Arshad MI
    World J Gastroenterol; 2021 Apr; 27(13):1296-1310. PubMed ID: 33833483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management.
    Li P; Liu Y; Cheng Z; Yu X; Li Y
    Biomed Pharmacother; 2022 Oct; 154():113568. PubMed ID: 36029543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination.
    Nevola R; Criscuolo L; Beccia D; Delle Femine A; Ruocco R; Imbriani S; Alfano M; Villani A; Russo A; Perillo P; Marfella R; Adinolfi LE; Sasso FC; Marrone A; Rinaldi L
    World J Gastroenterol; 2023 Feb; 29(5):800-814. PubMed ID: 36816617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Risk Factors for the Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Positivity in Patients With Coronavirus Disease 2019.
    Lin A; He ZB; Zhang S; Zhang JG; Zhang X; Yan WH
    Clin Infect Dis; 2020 Nov; 71(16):2061-2065. PubMed ID: 32337591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver infection and COVID-19: the electron microscopy proof and revision of the literature.
    Pirisi M; Rigamonti C; D'Alfonso S; Nebuloni M; Fanni D; Gerosa C; Orrù G; Venanzi Rullo E; Pavone P; Faa G; Saba L; Boldorini R
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2146-2151. PubMed ID: 33660834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 basics and vaccine development with a Canadian perspective.
    Liu M; Chen X
    Can J Microbiol; 2021 Feb; 67(2):112-118. PubMed ID: 33136431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver.
    Aghemo A; Masarone M; Montagnese S; Petta S; Ponziani FR; Russo FP;
    Dig Liver Dis; 2020 Sep; 52(9):937-941. PubMed ID: 32703730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
    Harrell CR; Jovicic BP; Djonov V; Volarevic V
    Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Adhikari EH; Moreno W; Zofkie AC; MacDonald L; McIntire DD; Collins RRJ; Spong CY
    JAMA Netw Open; 2020 Nov; 3(11):e2029256. PubMed ID: 33211113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.